Tag: COVID-19

spot_imgspot_img

‘‘A living WHO guideline on drugs for COVID-19’’: The Eighth version (Seventh update) Released

The eighth version (seventh update) of a living guideline is released. It replaces earlier versions. The latest update includes a strong recommendation for the...

Deltacron is not a New Strain or Variant

Deltacron is not a new strain or variant but a case of co-infection with two variants of SARS-CoV-2. Over the past two years, different...

Nuvaxovid & Covovax: the 10th & 9th COVID-19 vaccines in WHO’s Emergency Use List

Following assessment and approval by the European Medicines Agency (EMA), WHO has issued an emergency use listing (EUL) for Nuvaxovid on 21 December 2021. Earlier on...

Why Omicron Should be Taken Seriously

Evidences so far suggest that Omicron variant of SARS-CoV-2 has high transmission rate but fortunately is low on virulence and is not usually leading...

WHO’s Interim recommendations for the use of One-dose Janssen Ad26.COV2.S (COVID-19) vaccine

Single dose of the vaccine can increase vaccine coverage rapidly which is an imperative in many countries where level of vaccine uptake is not optimal.   WHO...

Future of Adenovirus based COVID-19 Vaccines (such as Oxford AstraZeneca) in light of recent finding about Cause of rare side effects of Blood clot

Three adenoviruses used as vectors to produce COVID-19 vaccines, bind to platelet factor 4 (PF4), a protein implicated in the pathogenesis of clotting disorders.  Adenovirus...